Komori
Bando Chemical Industries (5195) · InitiativeRestated

Applying Hyperinflationary Accounting to Turkish Subsidiaries

First written in FY2023-Q1. 2 of 3 entries say "Restated". Latest entry: FY2023-Q3.

3entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2023-Q1 – FY2023-Q32022: 220222023: 12023
Same theme, other companies
Impact on Consolidated Profit or Loss of Hyperinflation Accounting for a Turkish SubsidiaryA theme 21 companies write about · 14 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2024: 2 of 14 companies on the "Worse" side.

12 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 21 companies compared. The sentences above are computed from all 21.
Full recordFilings, disclosures and news, newest first
  1. FY2023-Q3RestatedAnnual report

    「From the cumulative first-quarter period, the Group has incorporated the financial statements of its Turkish subsidiary into the consolidated financial statements in accordance with IAS 29, Financial Reporting in Hyperinflationary Economies, by restating them in terms of the measuring unit current at the end of the period and reflecting the effects of inflation in Turkey.」

    The application of hyperinflationary accounting under IAS 29 to the Turkish subsidiary has continued, and its impact on the consolidated financial statements for the third quarter was described as immaterial.
  2. FY2023-Q2RestatedAnnual report

    「From the cumulative first-quarter period, the Group has incorporated the financial statements of its Turkish subsidiary into the consolidated financial statements in accordance with IAS 29, Financial Reporting in Hyperinflationary Economies, by restating them in terms of the measuring unit current at the end of the period and reflecting the effects of inflation in Turkey.」

    The application of hyperinflationary accounting under IAS 29 to the Turkish subsidiary has continued, and its impact on the consolidated financial statements for the second quarter was described as immaterial.
  3. FY2023-Q1First statedAnnual report

    「From the cumulative first-quarter period, the Group has incorporated the financial statements of its Turkish subsidiary into the consolidated financial statements in accordance with IAS 29, Financial Reporting in Hyperinflationary Economies, by restating them in terms of the measuring unit current at the end of the period and reflecting the effects of inflation in Turkey. For the financial statements of foreign operations in hyperinflationary economies, revenue and expenses are also translated into Japanese yen using the exchange rate at the end of the period, as required by IAS 21, The Effects of Changes in Foreign Exchange Rates. The impact on the consolidated financial statements for the first quarter was immaterial.」

    From the first quarter, hyperinflationary accounting under IAS 29 and translation under IAS 21 were applied to the Turkish subsidiary. The impact on the financial statements was described as immaterial.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Bando Chemical Industries yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.